Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0143 | 0.0416 | 0.1943 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0143 | 0.0416 | 0.1943 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.2098 | 0.2509 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.2098 | 0.2509 |
Plasmodium vivax | protein kinase Crk2 | 0.0143 | 0.0416 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0143 | 0.0416 | 0.1239 |
Echinococcus granulosus | cyclin dependent kinase 5 activator 1 | 0.0836 | 0.8359 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0143 | 0.0416 | 0.0416 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0143 | 0.0416 | 0.1943 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0143 | 0.0416 | 1 |
Plasmodium falciparum | protein kinase 5 | 0.0143 | 0.0416 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0143 | 0.0416 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 5 activator 1 | 0.0836 | 0.8359 | 0.8359 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0143 | 0.0416 | 0.0498 |
Giardia lamblia | Kinase, CMGC CDK | 0.0143 | 0.0416 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0294 | 0.2144 | 0.6378 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0143 | 0.0416 | 0.0498 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0294 | 0.2144 | 0.2564 |
Echinococcus granulosus | cyclin dependent kinase | 0.0143 | 0.0416 | 0.0498 |
Loa Loa (eye worm) | hypothetical protein | 0.04 | 0.3361 | 0.4021 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0143 | 0.0416 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0143 | 0.0416 | 0.0498 |
Onchocerca volvulus | 0.0107 | 0 | 0.5 | |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.0143 | 0.0416 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0143 | 0.0416 | 0.0498 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0294 | 0.2144 | 1 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0143 | 0.0416 | 0.1943 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0294 | 0.2144 | 1 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK1 protein kinase | 0.0294 | 0.2144 | 0.2564 |
Entamoeba histolytica | hypothetical protein | 0.0294 | 0.2144 | 1 |
Brugia malayi | hypothetical protein | 0.04 | 0.3361 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0836 | 0.8359 | 1 |
Echinococcus multilocularis | dual specificity | 0.0294 | 0.2144 | 0.2144 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0143 | 0.0416 | 0.0498 |
Schistosoma mansoni | cyclin-dependent kinase 5 activator | 0.0836 | 0.8359 | 1 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0143 | 0.0416 | 0.1943 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0143 | 0.0416 | 0.0498 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0143 | 0.0416 | 0.0416 |
Entamoeba histolytica | protein kinase, putative | 0.0294 | 0.2144 | 1 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0143 | 0.0416 | 0.0416 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0143 | 0.0416 | 0.1943 |
Entamoeba histolytica | protein kinase, putative | 0.0294 | 0.2144 | 1 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0143 | 0.0416 | 0.1943 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0143 | 0.0416 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.04 | 0.3361 | 0.4021 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0143 | 0.0416 | 0.1943 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0143 | 0.0416 | 0.1943 |
Leishmania major | serine/threonine-protein kinase, putative,protein kinase, putative | 0.0294 | 0.2144 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.037 | 0.0443 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0294 | 0.2144 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0143 | 0.0416 | 0.0416 |
Echinococcus granulosus | dual specificity | 0.0294 | 0.2144 | 0.2564 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0143 | 0.0416 | 0.0498 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0143 | 0.0416 | 0.1943 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0143 | 0.0416 | 0.0498 |
Brugia malayi | cell division control protein 2 homolog | 0.0143 | 0.0416 | 0.1239 |
Trypanosoma brucei | CMGC/DYRK protein kinase, putative | 0.0294 | 0.2144 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.2944 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.3535 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.